Arterial spin labeling: Pathologically proven superiority over conventional MRI for detection of high-grade glioma progression after treatment

被引:16
|
作者
Nyberg, Eric [1 ]
Honce, Justin [1 ]
Kleinschmidt-DeMasters, Bette K. [2 ,3 ]
Shukri, Brian [1 ]
Kreidler, Sarah [4 ]
Nagae, Lidia [1 ]
机构
[1] Univ Colorado Hosp, Dept Radiol, 12605 E 16th Ave, Aurora, CO 80045 USA
[2] Univ Colorado Hosp, Dept Pathol, Aurora, CO USA
[3] Univ Colorado Hosp, Dept Neurol & Neurosurg, Aurora, CO USA
[4] Neptune & Co Inc, Los Alamos, NM USA
关键词
Arterial spin labeling; MR perfusion; glioblastoma; radiation necrosis; pseudoprogression;
D O I
10.1177/1971400916665375
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
Background: Standard of care for high-grade gliomas (HGGs) includes surgical debulking and adjuvant chemotherapy and radiation. Patients under treatment require frequent clinical and imaging monitoring for therapy modulation. Differentiating tumor progression from treatment-related changes can be challenging on conventional MRI, resulting in delayed recognition of tumor progression. Arterial spin labeling (ASL) may be more sensitive for tumor progression. Materials and methods: ASL and associated conventional MR images obtained in patients previously treated for HGGs and before biopsy or re-resection were reviewed by three neuroradiologists who were blinded to the histopathologic results. Regions of interest (ROIs) of greatest perfusion were chosen by consensus, and mirror-image contralateral ROIs were also placed. Sensitivity of ASL for tumor progression was compared with those of contrast-enhanced T1-weighted (T1W-CE) and fluid-attenuated inversion recovery (FLAIR) images using McNemar's test. We tested for an association between cerebral blood flow (CBF) and apparent diffusion correlation (ADC) using a Hotelling-Lawley trace. Finally, we used a Pearson's analysis to test for a correlation between CBF and percentage of tumor within each resection. Results: Twenty-two patients were studied. ASL demonstrated hyperperfusion in all cases with mean CBF ratio 3.37 (+/-1.71). T1W-CE and FLAIR images were positive in 15 (p = 0.0233) and 16 (p = 0.0412) cases, respectively. There was no association between ADC and CBF (p = 0.687). There was a correlation between CBF and percentage of tumor (p = 0.048). Conclusion: ASL may be more sensitive than conventional MR sequences for the detection of tumor progression in patients treated for HGGs.
引用
收藏
页码:377 / 383
页数:7
相关论文
共 50 条
  • [41] Prolonged survival in patients with local chronic infection after high-grade glioma treatment: Two case reports
    Solar, Peter
    Mackerle, Zdenek
    Hendrych, Michal
    Pospisil, Petr
    Lakomy, Radek
    Valekova, Hana
    Hermanova, Marketa
    Jancalek, Radim
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [42] Prognostic value of blood flow estimated by arterial spin labeling and dynamic susceptibility contrast-enhanced MR imaging in high-grade gliomas
    Rau, Mandy Kim
    Braun, Christian
    Skardelly, Marco
    Schittenhelm, Jens
    Paulsen, Frank
    Bender, Benjamin
    Ernemann, Ulrike
    Bisdas, Sotirios
    JOURNAL OF NEURO-ONCOLOGY, 2014, 120 (03) : 557 - 566
  • [43] Prognostic value of blood flow estimated by arterial spin labeling and dynamic susceptibility contrast-enhanced MR imaging in high-grade gliomas
    Mandy Kim Rau
    Christian Braun
    Marco Skardelly
    Jens Schittenhelm
    Frank Paulsen
    Benjamin Bender
    Ulrike Ernemann
    Sotirios Bisdas
    Journal of Neuro-Oncology, 2014, 120 : 557 - 566
  • [44] Radiological Recurrence Patterns after Bevacizumab Treatment of Recurrent High-Grade Glioma: A Systematic Review and Meta-Analysis
    Cho, Se Jin
    Kim, Ho Sung
    Suh, Chong Hyun
    Park, Ji Eun
    KOREAN JOURNAL OF RADIOLOGY, 2020, 21 (07) : 908 - 918
  • [45] High-grade glioma imaging volumes and survival: a single-institution analysis of 101 patients after resection using intraoperative MRI
    Nicholas T. Gamboa
    Brendan Crabb
    Jeffrey Curran Henson
    Kyril L. Cole
    Bradley D. Weaver
    Michael Karsy
    Randy L. Jensen
    Journal of Neuro-Oncology, 2022, 160 : 555 - 565
  • [46] High-grade glioma imaging volumes and survival: a single-institution analysis of 101 patients after resection using intraoperative MRI
    Gamboa, Nicholas T.
    Crabb, Brendan
    Henson, Jeffrey Curran
    Cole, Kyril L.
    Weaver, Bradley D.
    Karsy, Michael
    Jensen, Randy L.
    JOURNAL OF NEURO-ONCOLOGY, 2022, 160 (03) : 555 - 565
  • [47] Comparison of different treatment schemes in 5-ALA interstitial photodynamic therapy for high-grade glioma in a preclinical model: An MRI study
    Vermandel, Maximilien
    Quidet, Mathilde
    Vignion-Dewalle, Anne-Sophie
    Leroy, Henri-Arthur
    Leroux, Bertrand
    Mordon, Serge
    Reyns, Nicolas
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2019, 25 : 166 - 176
  • [48] Diagnostic Accuracy of PET Tracers for the Differentiation of Tumor Progression from Treatment-Related Changes in High-Grade Glioma: A Systematic Review and Metaanalysis
    de Zwart, Paul L.
    van Dijken, Bait R. J.
    Holtman, Gea A.
    Stormezand, Gilles N.
    Dierckx, Rudi A. J. O.
    van Laar, Peter Jan
    van der Hoorn, Anouk
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (04) : 498 - 504
  • [49] Differentiating high-grade glioma progression from treatment-related changes with dynamic [18F]FDOPA PET: a multicentric study
    Rozenblum, Laura
    Zaragori, Timothee
    Tran, Suzanne
    Morales-Martinez, Andrea
    Taillandier, Luc
    Blonski, Marie
    Rech, Fabien
    Galanaud, Damien
    Kas, Aurelie
    Verger, Antoine
    EUROPEAN RADIOLOGY, 2023, 33 (04) : 2548 - 2560
  • [50] Systemic inflammatory markers and volume of enhancing tissue on post-contrast T1w MRI images in differentiating true tumor progression from pseudoprogression in high-grade glioma
    Satragno, Camilla
    Schiavetti, Irene
    Cella, Eugenia
    Piciche, Federica
    Falcitano, Laura
    Resaz, Martina
    Truffelli, Monica
    Caneva, Stefano
    Mattioli, Pietro
    Esposito, Daniela
    Ginulla, Alessio
    Scaffidi, Claudio
    Fiaschi, Pietro
    D'Andrea, Alessandro
    Bianconi, Andrea
    Zona, Gianluigi
    Barletta, Laura
    Roccatagliata, Luca
    Castellan, Lucio
    Morbelli, Silvia
    Bauckneht, Matteo
    Donegani, Isabella
    Nozza, Paolo
    Arnaldi, Dario
    Vidano, Giulia
    Gianelli, Flavio
    Barra, Salvina
    Bennicelli, Elisa
    Belgioia, Liliana
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 49